{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:04:54Z","timestamp":1794002694991,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005790","name":"Thammasat University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["RN279389\\u2013358033"],"award-info":[{"award-number":["RN279389\\u2013358033"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021570","name":"Strategy for Patient-Oriented Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024738","name":"Chulabhorn International College of Medicine, Thammasat University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1053\/j.gastro.2026.04.039","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:19:54Z","timestamp":1779200394000},"page":"667-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fecal Microbiota Transplantation for Symptom Improvement in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1053","volume":"171","author":[{"given":"Natsuda","family":"Aumpan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios I.","family":"Leontiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis K.L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moayyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2026.04.039_bib1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/gutjnl-2015-311240","article-title":"The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review","volume":"66","author":"Sperber","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.039_bib3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41575-023-00794-z","article-title":"Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management","volume":"20","author":"Staudacher","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.039_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/gast.2000.16484","article-title":"The impact of irritable bowel syndrome on health-related quality of life","volume":"119","author":"Gralnek","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S2468-1253(16)30023-1","article-title":"Pathophysiology of irritable bowel syndrome","volume":"1","author":"Holtmann","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.039_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut microbiota in patients with irritable bowel syndrome-a systematic review","volume":"157","author":"Pittayanon","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","article-title":"Intestinal microbiota in functional bowel disorders: a Rome foundation report","volume":"62","author":"Simren","year":"2013","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.039_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jcag\/gwy071","article-title":"Canadian Association of Gastroenterology clinical practice guideline for the management of irritable bowel syndrome (IBS)","volume":"2","author":"Moayyedi","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.039_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.039_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.gastro.2024.01.008","article-title":"AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases","volume":"166","author":"Peery","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study","volume":"69","author":"El-Salhy","year":"2020","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.039_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2020.07.013","article-title":"Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: short- and long-term results from a placebo-controlled randomized trial","volume":"160","author":"Holvoet","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","article-title":"Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial","volume":"3","author":"Johnsen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.039_bib14","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/gutjnl-2018-316434","article-title":"Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study","volume":"67","author":"Halkj\u00e6r","year":"2018","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.039_bib15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2468-1253(19)30198-0","article-title":"Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial","volume":"4","author":"Aroniadis","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.039_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12876-024-03311-x","article-title":"A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.039_bib17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s40001-024-02046-5","article-title":"Clinical efficacy and safety of faecal microbiota transplantation in the treatment of irritable bowel syndrome: a systematic review, meta-analysis and trial sequential analysis","volume":"29","author":"Lo","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1053\/j.gastro.2026.04.039_bib18","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.3748\/wjg.v29.i20.3185","article-title":"Fecal microbiota transplantation for the treatment of irritable bowel syndrome: a systematic review and meta-analysis","volume":"29","author":"Halkjaer","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.039_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914562","article-title":"Fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Jamshidi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.gastro.2026.04.039_bib20","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2026.04.039_bib21","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2026.04.039_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jclinepi.2020.09.018","article-title":"GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence\u2014an overview in the context of health decision-making","volume":"129","author":"Brozek","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.gastro.2026.04.039_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1053\/j.gastro.2026.04.039_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2026.04.039_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2026.04.039_bib26","article-title":"Efficacy of encapsulated fecal microbiota transplantation and FMT via rectal enema for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial (CAP-ENEMA FMT Trial)","volume":"12","author":"Aumpan","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1053\/j.gastro.2026.04.039_bib27","doi-asserted-by":"crossref","first-page":"11885","DOI":"10.1080\/21655979.2021.1999374","article-title":"Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules","volume":"12","author":"Guo","year":"2021","journal-title":"Bioengineered"},{"key":"10.1053\/j.gastro.2026.04.039_bib28","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000034","article-title":"The effect of allogenic versus autologous fecal microbiota transfer on symptoms, visceral perception and fecal and mucosal microbiota in irritable bowel syndrome: a randomized controlled study","volume":"10","author":"Holster","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.039_bib29","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/apt.15740","article-title":"Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome","volume":"51","author":"Lahtinen","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.04.039_bib30","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/microorganisms10091819","article-title":"The effect of anaerobically cultivated human intestinal microbiota compared to fecal microbiota transplantation on gut microbiota profile and symptoms of irritable bowel syndrome, a double-blind placebo-controlled study","volume":"10","author":"Mazzawi","year":"2022","journal-title":"Microorganisms"},{"key":"10.1053\/j.gastro.2026.04.039_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.2020067","article-title":"Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D","volume":"14","author":"Singh","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1053\/j.gastro.2026.04.039_bib32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/apt.17703","article-title":"Randomised clinical trial: faecal microbiota transplantation for irritable bowel syndrome with diarrhoea","volume":"58","author":"Yau","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.04.039_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000540420","article-title":"Efficacy of donor-recipient-matched faecal microbiota transplantation in patients with IBS-D: a single-centre, randomized, double-blind placebo-controlled study","volume":"105","author":"Zhang","year":"2024","journal-title":"Digestion"},{"key":"10.1053\/j.gastro.2026.04.039_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.023","article-title":"The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial","volume":"51","author":"Johnsen","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1053\/j.gastro.2026.04.039_bib35","article-title":"Fecal microbiota transplantation in irritable bowel syndrome: a meta-analysis of randomized controlled trials","volume":"9","author":"Samuthpongtorn","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1053\/j.gastro.2026.04.039_bib36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cgh.2023.09.001","article-title":"Long-term safety outcomes of fecal microbiota transplantation: real-world data over 8 years from the Hong Kong FMT Registry","volume":"22","author":"Yau","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.04.039_bib37","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1053\/j.gastro.2024.04.032","article-title":"Gastrointestinal biofilms: endoscopic detection, disease relevance, and therapeutic strategies","volume":"167","author":"Jandl","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib38","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41380-023-01972-w","article-title":"The neurobiology of irritable bowel syndrome","volume":"28","author":"Mayer","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1053\/j.gastro.2026.04.039_bib39","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2024.05.010","article-title":"Effect of brain-gut behavioral treatments on abdominal pain in irritable bowel syndrome: systematic review and network meta-analysis","volume":"167","author":"Goodoory","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.gastro.2015.06.021","article-title":"Symptom generation by mucosal inflammation in irritable bowel syndrome","volume":"149","author":"Sarna","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2024.01.045","article-title":"Chronic visceral pain: new peripheral mechanistic insights and resulting treatments","volume":"166","author":"Ford","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib42","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1053\/j.gastro.2024.07.004","article-title":"Molecular mechanisms underlying loss of vascular and epithelial integrity in irritable bowel syndrome","volume":"167","author":"Barbaro","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.gastro.2024.08.033","article-title":"Intestinal permeability in disorders of gut-brain interaction: from bench to bedside","volume":"168","author":"Grover","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology monograph on management of irritable bowel syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.04.039_bib45","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2025.05.016","article-title":"Efficacy of ACupuncTure in Irritable bOwel syNdrome (ACTION): a multicenter randomized controlled trial","volume":"169","author":"Yang","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib46","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.3390\/nu15132956","article-title":"Dietary implications of the bidirectional relationship between the gut microflora and inflammatory diseases with special emphasis on irritable bowel disease: current and future perspective","volume":"15","author":"Aziz","year":"2023","journal-title":"Nutrients"},{"key":"10.1053\/j.gastro.2026.04.039_bib47","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/gutjnl-2015-311339","article-title":"FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial","volume":"66","author":"McIntosh","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.04.039_bib48","doi-asserted-by":"crossref","first-page":"S-60","DOI":"10.1016\/S0016-5085(25)01094-7","article-title":"Efficient metabolism of tryptophan by microbes activates the aryl hydrocarbon receptor and reduces intestinal inflammation in humanized and gnotobiotic mice","volume":"169","author":"Rondeau","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib49","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41591-022-01964-3","article-title":"Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases","volume":"28","author":"Ianiro","year":"2022","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2026.04.039_bib50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.04.039_bib51","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1038\/s41467-025-58673-x","article-title":"Detecting microbial engraftment after FMT using placebo sequencing and culture enriched metagenomics to sort signals from noise","volume":"16","author":"Shekarriz","year":"2025","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2026.04.039_bib52","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526068745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526068745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:11:50Z","timestamp":1793754710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508526068745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0016508526068745"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2026.04.039","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal Microbiota Transplantation for Symptom Improvement in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2026.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}